Anebulo Pharmaceuticals, Inc. (ANEB) Reports In-Line Q4 EPS

Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) reported Q4 EPS of ($0.05), in-line with the analyst estimate of ($0.05).

For earnings history and earnings-related data on Anebulo Pharmaceuticals, Inc. (ANEB) click here.

You May Also Be Interested In

• Raymond James on Whirlpool Corporation (WHR): 'July Major Appliance Industrial Production Remained Weak'
• Coty (COTY) call put ratio 4.2 calls to 1 put with a focus on August 3 calls into quarter results
• TJX Cos. (TJX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance